After keeping the novel coronavirus "largely in check" over the summer, Alaska is now facing an increasing infection rate amid cooling temperatures and a populace fatigued with social restrictions—a scenario that serves as "an early warning sign" for the rest of the country "that winter could bring the most devastating phase of the [epidemic]," Mike Baker writes for the New York Times.
The Department of Justice on Wednesday announced that Purdue Pharma has agreed to plead guilty to three felony criminal charges related to its marketing of its opioid painkillers under a $8.3 billion settlement, in today's bite-sized hospital and health industry news from Connecticut and the District of Columbia.
FDA on Thursday approved Gilead Sciences's antiviral drug remdesivir for hospitalized adults and children older than 12 with Covid-19, making remdesivir the first drug approved by the agency to treat the disease caused by the novel coronavirus.
Healthgrades on Tuesday released its 2021 analysis of the top hospitals in the United States, which evaluated the performance of almost 4,500 hospitals and assessed clinical outcomes for 34 procedures and conditions across 16 specialty areas. Find out where your hospital ranked.
Last night, President Trump and former Vice President Joe Biden squared off in the last presidential debate before Election Day—and once again, America's coronavirus epidemic and the Affordable Care Act were front and center. Daily Briefing's Ashley Fuoco Antonelli breaks down what you need to know.
Print All Daily Briefing Article from
Have a Question?
Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.